Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial-Reference-Cited by-同舟云学术

Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial

Published:2022-12 Issue: Volume:157 Page:105328
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Chuang Chih-Hsien^ORCID,Huang Chung-Guei^ORCID,Huang Ching-Tai,Chen Yi-Ching,Kung Yu-An,Chen Chih-Jung,Chuang Tzu-Chun,Liu Ching-Chi,Huang Po-Wei,Yang Shu-Li,Gu Po-Wen,Shih Shin-Ru,Chiu Cheng-Hsun

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference36 articles.

1. Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization;Doria-Rose;medRxiv,2021

2. SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3;Falsey;N. Engl. J. Med.,2021

3. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant;Lopez Bernal;N. Engl. J. Med.,2021

4. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa;Viana;Nature,2022

5. SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons;Rössler;N. Engl. J. Med.,2022

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives;Journal of the Formosan Medical Association;2024-08

2. Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis;Expert Review of Vaccines;2024-02-26

3. Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection;Vaccines;2024-01-06

4. Immunogenicity of Second Booster-Dose COVID-19 mRNA Vaccine Among Older Adults in Taiwan;2024

5. Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses;Memórias do Instituto Oswaldo Cruz;2024